Resources

With the objective to provide quick, high-quality, and accessible COVID-19 testing, PATH implemented a decentralized rapid diagnostic system using Abbott ID NOW and Panbio RDT in Sangamner in Ahmednagar district, Maharashtra. This document outlines the course of the intervention from implementation to impact.

For more than 15 years, the M.J. Murdock Charitable Trust has partnered with PATH to improve public health capacity. This brief highlights a few examples of how the Murdock Trust has supported PATH’s in-house product development shop, helped strengthen digital health capabilities and even furthered the Primary Health Care (PHC) agenda. PATH is grateful for this long-standing partnership and the important public health work that it enables.

The COVID-19 pandemic has highlighted the need for oxygen and other respiratory care supplies and equipment around the globe.In response, PATH conducted a biomedical equipment survey in eight government-owned health facilities in Zambia. The purpose of this survey was to quantify existing oxygen delivery and production equipment, consumables for administering oxygen therapy, bed capacity, and facility infrastructure characteristics that are relevant to providing respiratory care. The results indicated that all assessed institutions need urgent procurement of medical equipment for oxygen delivery, monitoring devices to support safe oxygen administration to patients, and accompanying consumables. Also, across all facilities there is insufficient staff trained to adequately manage COVID-19 patients requiring respiratory care.This report summarizes observations from the collected data and is intended to help global and national stakeholders understand COVID-19 treatment capacity in Zambia.

This document provides a historical overview and current status of technologies that support injection safety such as autodisable (AD) syringes, reuse prevention syringes (RUP), sharps injury prevention (SIP) syringes, disposable-syringe jet injectors, and compact prefilled autodisable (CPAD). It also documents the global progress over the past two decades that have led to a significant reduction in bloodborne pathogen transmission and the continued efforts needed to sustain the gains that have been made and to eliminate disease transmission from needlestick injuries and misuse of syringes.

This document provides a historical overview and current status of technologies that support injection safety such as autodisable (AD) syringes, reuse prevention syringes (RUP), sharps injury prevention (SIP) syringes, disposable-syringe jet injectors, and compact prefilled autodisable (CPAD). It also documents the global progress over the past two decades that have led to a significant reduction in bloodborne pathogen transmission and the continued efforts needed to sustain the gains that have been made and to eliminate disease transmission from needlestick injuries and misuse of syringes.